Thursday, July 23, 2026

pharma · Systemic Lupus Erythematosus

Santhera Pharmaceuticals Holding

Santhera Pharmaceuticals Holding drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Pratteln, CH HQ
2004 Founded
115 Employees
EMA registrant Type
Company details
Status
Public
HQ
Pratteln, CH
Founded
2004
Employees
115
Programs
2
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Santhera Pharmaceuticals Holding pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Santhera Pharmaceuticals Holding drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →